National Science Foundation

Students looking to work in state-of-the-art computer science and engineering facilities should look no further than the University of Nebraska at Omaha. UNO is a leader Bioinformatics, Computer Science and Management Information Systems programs. But UNO is not merely a four-year state university focused on science. With approximately 200 academic programs, this school offers an intimate atmosphere in a thriving city with numerous employment options for future graduates. The University of Nebraska at Omaha implements the Four-Year Guarantee resolution, meaning that the university will design a curriculum dedicated to permitting students to graduate as quickly as possible. UNO has a non-refundable $45 application fee for all applicants. The admissions requirements are based on core course prerequisites and performance requirements. The performance requirements for UNO admissions are a rank in the upper half of your graduating high school class and an ACT score of 20 or higher. The core course requirements are similar to the core requirements of other four-year colleges. UNO offers several types of financial aid to ease the cost of tuition. Not only do they have federal and state programs, but the school also offers scholarships, work-study programs and loans.

Epicrop Technologies, Inc. is a biotechnology company based in Lincoln, Nebraska, founded in 2013. It specializes in developing epigenetic technology aimed at enhancing crop yields across all plant species. The company's innovative approach focuses on improving crop development and increasing tolerance to abiotic stressors, which are environmental factors that can adversely affect plant growth. By applying these epigenetic methods, Epicrop enables farmers to boost their crop yields while maintaining lower prices, ultimately supporting agricultural productivity and sustainability.

DTN is a provider of real-time business intelligence that serves various sectors, including agriculture, energy, weather, financial analytics, and transportation. Founded in 1984 and headquartered in Omaha, Nebraska, with additional offices across several states, DTN delivers operationally-critical insights through analytics and machine learning. The company utilizes the Internet, satellite, and data feed connections to provide news, information, and analysis, empowering clients to make informed business decisions. Its services cater to industries such as commodities trading, public safety, aviation, construction, and turf management, enabling organizations with complex supply chains to navigate challenges effectively. DTN operates as a subsidiary of Telvent Git S.A.

Ground Fluor Pharmaceuticals, Inc. is a biomedical company based in Lincoln, Nebraska, specializing in fluorine chemistry solutions for positron emission tomography (PET) imaging. Established in 2012, the company develops and provides imaging agents that are essential for the diagnosis and management of various diseases. Ground Fluor Pharmaceuticals has pioneered new chemistry technology that simplifies and enhances fluorine synthesis processes, making them more efficient and cost-effective. This innovation stems from research conducted at the University of Nebraska and Massachusetts General Hospital, supported by the National Science Foundation and Cedarville Investments, Ltd. The company also supplies pharmaceutical intermediates, such as diaryliodonium and aryliodonium ylide, further contributing to the production of PET imaging agents. Through its proprietary chemical technologies, Ground Fluor Pharmaceuticals enables clients to achieve higher yields and potency in fluorine production for medical imaging applications.

Ground Fluor Pharmaceuticals, Inc. is a biomedical company based in Lincoln, Nebraska, specializing in fluorine chemistry solutions for positron emission tomography (PET) imaging. Established in 2012, the company develops and provides imaging agents that are essential for the diagnosis and management of various diseases. Ground Fluor Pharmaceuticals has pioneered new chemistry technology that simplifies and enhances fluorine synthesis processes, making them more efficient and cost-effective. This innovation stems from research conducted at the University of Nebraska and Massachusetts General Hospital, supported by the National Science Foundation and Cedarville Investments, Ltd. The company also supplies pharmaceutical intermediates, such as diaryliodonium and aryliodonium ylide, further contributing to the production of PET imaging agents. Through its proprietary chemical technologies, Ground Fluor Pharmaceuticals enables clients to achieve higher yields and potency in fluorine production for medical imaging applications.